TY - JOUR
T1 - Consumer interest in community pharmacy HIV screening services
AU - Darin, Kristin M.
AU - Scarsi, Kimberly K.
AU - Klepser, Donald G.
AU - Klepser, Stephanie A.
AU - Reeves, Andrew
AU - Young, Maria
AU - Klepser, Michael E.
N1 - Funding Information:
Disclosure: Drs. Donald G. Klepser, Stephanie A. Klepser, and Michael E. Klepser have received grants from the National Association of Chain Drug Stores Foundation and Gilead Sciences, Inc. for projects related to rapid diagnostic testing and are co-creators of the point-of-care testing certificate program administered by the Michigan Pharmacists Association. The authors declare no other relevant conflicts of interest or financial relationships.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Objective: To evaluate consumers' interest in pharmacist-provided human immunodeficiency virus (HIV) screening and to evaluate potential barriers and facilitators to HIV screening in the community pharmacy setting. Methods: Cross-sectional survey of adult patients who presented to one of five community (chain and independent) pharmacies from November 2010 to August 2011. Results: Based on 380 usable surveys, 135 (35.8%) participants were interested in pharmacy-based HIV screening. Independent predictors of interest in HIV screening identified in multivariate analysis (reference groups: ages 30 to 49 years old and white, non-Hispanic race) included younger age (18 to 29 years old) (odds ratio [OR], 2.48; 95% confidence interval [CI], 1.31 to 4.71); black, non-Hispanic race (OR, 2.37; CI, 1.40 to 4.03); and other race (OR, 4.58; CI, 1.63 to 12.87). Lack of perceived risk for HIV was the most commonly cited barrier to HIV screening; and free, rapid, or confidential HIV testing were identified as potential facilitators. Conclusion: Interest in pharmacy-based HIV screening was high among participants representing age and race groups disproportionately affected by HIV. Expansion of HIV screening efforts to community pharmacies warrants further consideration.
AB - Objective: To evaluate consumers' interest in pharmacist-provided human immunodeficiency virus (HIV) screening and to evaluate potential barriers and facilitators to HIV screening in the community pharmacy setting. Methods: Cross-sectional survey of adult patients who presented to one of five community (chain and independent) pharmacies from November 2010 to August 2011. Results: Based on 380 usable surveys, 135 (35.8%) participants were interested in pharmacy-based HIV screening. Independent predictors of interest in HIV screening identified in multivariate analysis (reference groups: ages 30 to 49 years old and white, non-Hispanic race) included younger age (18 to 29 years old) (odds ratio [OR], 2.48; 95% confidence interval [CI], 1.31 to 4.71); black, non-Hispanic race (OR, 2.37; CI, 1.40 to 4.03); and other race (OR, 4.58; CI, 1.63 to 12.87). Lack of perceived risk for HIV was the most commonly cited barrier to HIV screening; and free, rapid, or confidential HIV testing were identified as potential facilitators. Conclusion: Interest in pharmacy-based HIV screening was high among participants representing age and race groups disproportionately affected by HIV. Expansion of HIV screening efforts to community pharmacies warrants further consideration.
UR - http://www.scopus.com/inward/record.url?scp=84920964296&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920964296&partnerID=8YFLogxK
U2 - 10.1331/JAPhA.2015.14069
DO - 10.1331/JAPhA.2015.14069
M3 - Article
C2 - 25414989
AN - SCOPUS:84920964296
SN - 1544-3191
VL - 55
SP - 67
EP - 72
JO - Journal of the American Pharmacists Association
JF - Journal of the American Pharmacists Association
IS - 1
ER -
